Novadip Biosciences
PrivateLast Round
Convertible Debt
Sep 21, 2026
Total Funding Raised
$108.54M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Novadip Biosciences is a biotechnology company that develops regenerative tissue products to accelerate healing for large bone defects, bone non-union, and spine fusion.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novadip Biosciences Comparables
Compare Novadip Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpiBone | 86% | |
| Bonus Biogroup | 78% | |
| Theradaptive | 78% |
Novadip Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 21, 2026 | ||||
| Debt | Dec 14, 2023 | ||||
| Series B Extension | Nov 3, 2022 | ||||
| Series B | Oct 28, 2021 | ||||
| Series A | Sep 10, 2015 |
Key People
Founding team and executive leadership
Novadip Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A |
| Sopartec | Convertible Debt, Series B, Series A, Series B Extension |
| Noshaq | Convertible Debt |
| Epimede | Series A |
| Fund+ | Convertible Debt, Series A, Series B, Series B Extension |
| Société Régionale d'Investissement de Wallonie | Series A |
| Investsud | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
$12M round led by New Science Ventures
- Aug 21, 2026
Monthly visitors grew 110% MoM, from 3.6K to 7.6K.
Recent news
Latest coverage and updates
- is_developingSep 21, 2026
Novadip is developing NVD003 on Sep 21st '26.
- receives_financingSep 21, 2026
Novadip received financing of $11.9M in convertible financing round on Sep 21st '26.
Novadip Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Novadip Biosciences's valuation, stock price, and market status.
Is NOVADIP a public or private company?
NOVADIP is a private company.
What is the current stock price of NOVADIP?
NOVADIP is a private company with no public stock price. No recent secondary market data is available.
How much is NOVADIP worth (valuation)?
Valuation information for NOVADIP is not publicly available.
Can I buy NOVADIP stock?
NOVADIP shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NOVADIP's last funding round?
NOVADIP's most recent funding round was Debt on December 14, 2023.
Who are the main investors in NOVADIP?
Key investors in NOVADIP include Fund+, European Investment Bank Group, New Science Ventures.
Will NOVADIP IPO soon?
No public IPO plans have been announced for NOVADIP.
How can I track NOVADIP secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NOVADIP's secondary market activity and sign up for updates.